Meanwhile, substantial investigations are also ongoing to develop ASO therapeutics for PD and AD, including ASOs to suppress PTBP1 that have been tried in several studies both in vitro and in animal models [24, 25]. Here, PTBP1 is linked to Alzheimer disease.